mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.098 |
0.004 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.19 |
0.004 |
mRNA |
PD-0332991 |
CCLE |
pan-cancer |
AAC |
-0.15 |
0.004 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.006 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.007 |